Last week the Queensland Government announced it was extending its trial of pharmacists prescribing antibiotics for uncomplicated UTIs.

Without a reality check, the move could see prescribing becoming a permanent feature in the pharmacist’s arsenal. 

But do pharmacists really know what they’re letting themselves in for? 

The clinical problems of misdiagnosis and mismanagement are obvious but so are the risks associated with the chemists’ conflict of financial interests.